SEC Tracker
Get the app

Harmony Biosciences Holdings HRMY

Harmony Biosciences Reports First Quarter 2022 Financial Results and Business Updates

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 99.1
Press release
  • Reports quarterly results (2.02)
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Harmony Biosciences Holdings files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Travere Therapeutics TVTX public float $1.3B, Jun 30, 2025
  2. Ani Pharmaceuticals ANIP public float $1.3B, Jun 30, 2025
  3. Celldex Therapeutics CLDX public float $1.3B, Jun 30, 2025
  4. Adaptive Biotechnologies ADPT public float $1.4B, Jun 30, 2025
  5. Innoviva INVA public float $1.3B, Jun 30, 2025